After business, knowledge and legal process outsourcing, the Indianindustries are now eying 'diagnostics jobs' outsourcing from othercountries. According to industry experts, a number of hospitals in the US andEurope are outsourcing laboratory and diagnostic tests to India as ithelps in saving cost and money while maintaining quality. The Indiandiagnostics and pathology laboratory business is around USD 864 millionand is growing at a rate of 20 per cent annually, they say. According to FICCI, the size of the global clinical trials market wasnearly USD 10 billion and predicted to have touched by USD 26 billionby 2007. "Diagnostics and lab testing outsourcing is certainly the mostpotential business domain. We are trying to tap available opportunitiesin it," says Dr G S K Velu, Managing Director, Metropolis HealthServices India Ltd. "There is an excellent outsourcing opportunity totest around one million samples a year," he says. The other emerging sector --Clinical Research Outsourcing (CRO) -- isalso witnessing surge in the country. The drug manufacturing units areoutsourcing different phases relating to development of medicine toIndia. In the case of diagnostics, X-rays and other procedures are doneabroad and the reports by experts are written here and sent back, whilein the case of lab tests,the photomicrographs are electronically senthere and the doctors send back the results, says Velu. We plan tooffer tele-pathology services to cater to the needs of foreign clientsfaster, he says adding that countries like Middle East, Srilanka,Africa, Nepal, Bangladesh and UK outsource tests to India. At present,the volume is not very high but the market potential is huge asEuropean countries as also the US are in talks to outsource their workin this area. Metropolis, that provides hospital Laboratory management services andoutsource number of diagnostic related works to India, has number oflabs in Middle East and South-East Asian countries, including Thailand,Indonesia and Vietnam. "We processes more than 10 million sample tests per year and around oneper cent from outsourcing, Velu adds. "There is a great opportunityfor tapping CRO in the nation. The volume of business is expected totouch USD 1-1.5 bn mark by 2010," said Dr Umakanta Sahoo, ManagingDirector, Chiltren International, a global CRO firm. There are as many as 30 Global CROs and 100 companies involved in doingclinical research related jobs in the country. Most of the work comes from US (almost 20 per cent) and Europe (70-80per cent). We undertake approximately 300 studies a year, he says. "It is not the lack of expertise behind outsourcing Clinical Researchrelated jobs. But, availability of manpower and time saving," he says. The sector is also poised to deliver excellent job opportunity andcareer options to research fellows. McKinsey estimated that the IndianCR (clinical research) market will grow to USD 1.5 billion in value by2010. "Research job is not regarded much in our country. We need totrain researchers to meet the growing demands in CRO," he added.Asserting that the country has bouquet of products to offer to foreignclients and attract outsourcing, he said "There is urgent need tomarket our products globally. The government has to start speakingglobally about diagnostics and lab work outsourcing in the same way asinformation technology.